NEW YORK, March 16, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Platform Specialty Products Corporation ("Platform Specialty Products" or the "Company") (NYSE: PAH). Such investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. 9980.
The investigation concerns whether Platform Specialty Products and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On March 14, 2016, The Wall Street Journal reported that Platform Specialty Products is conducting a foreign bribery investigation of third-party payments in West Africa made by Arysta LifeScience Limited, a recently acquired company, and has notified U.S. authorities of the probe.
On this news, Platform Specialty Products stock fell $0.62 per share, or 7.23%, to close at $7.95 per share on March 15, 2016.
The Pomerantz Firm, with offices in New York, Chicago, Beverly Hills, and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
Robert S. Willoughby
SOURCE Pomerantz LLP